Biologics research and production have grown rapidly in the past few decades, with no signs of slowing down. As innovators navigate an increasingly varied landscape of biological drugs designed to target everything from cancer to infectious diseases, many challenges still face those developing these next-generation therapeutics.
Download this CAS white paper to uncover global trends in biologics-focused drug discovery, factors contributing to continued growth in the space, and challenges faced by companies looking to invest in this shifting market.
